These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21851186)

  • 1. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.
    Skoogh J; Steineck G; Stierner U; Cavallin-Ståhl E; Wilderäng U; Wallin A; Gatz M; Johansson B;
    Acta Oncol; 2012 Feb; 51(2):185-97. PubMed ID: 21851186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
    Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
    Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
    J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
    Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC
    J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological needs when diagnosed with testicular cancer: findings from a population-based study with long-term follow-up.
    Skoogh J; Steineck G; Johansson B; Wilderäng U; Stierner U;
    BJU Int; 2013 Jun; 111(8):1287-93. PubMed ID: 23469865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular and cardiac autonomic function in survivors of testicular cancer.
    Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Hoekstra HJ; Sluiter WJ; Gietema JA
    Eur J Clin Invest; 2005 Feb; 35(2):99-103. PubMed ID: 15667580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
    Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
    Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function in long-term survivors of testicular cancer.
    Haugnes HS; Aass N; Fosså SD; Dahl O; Brydøy M; Aasebø U; Wilsgaard T; Bremnes RM
    J Clin Oncol; 2009 Jun; 27(17):2779-86. PubMed ID: 19414680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors.
    Skoogh J; Steineck G; Cavallin-Ståhl E; Wilderäng U; Håkansson UK; Johansson B; Stierner U;
    Int J Androl; 2011 Apr; 34(2):183-92. PubMed ID: 20550599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in long-term survivors of testicular cancer.
    Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
    Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility after testicular cancer treatments: results of a large multicenter study.
    Huyghe E; Matsuda T; Daudin M; Chevreau C; Bachaud JM; Plante P; Bujan L; Thonneau P
    Cancer; 2004 Feb; 100(4):732-7. PubMed ID: 14770428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
    Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
    Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
    Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
    J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paternity following treatment for testicular cancer.
    Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
    J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
    Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
    Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.